The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
Yale University's Department of Psychology is known for its world-class research and education in cognitive, social, and clinical psychology, aiming to understand and improve mental health and behavior.
The Department of Psychology and Behavioural Sciences at Aarhus BSS is part of Aarhus University, one of the five faculties. The department conducts research and teaching within all significant fields of psychology and contributes to society through research and knowledge exchange. Researchers collaborate nationally and internationally across various academic disciplines.
Pavlovia is a place for the wide community of researchers in the behavioural sciences to run, share, and explore experiments online.